
It’s in their genes: Virica Biotech partners with U.K. firm on cancer-fighting treatments
Ottawa firm inks deal to help Oxford Biomedica improve the yield and production efficiency of its next-generation gene therapies.

It’s in their genes: Virica Biotech partners with U.K. firm on cancer-fighting treatments
Ottawa firm inks deal to help Oxford Biomedica improve the yield and production efficiency of its next-generation gene therapies.

Company’s revenues have more than doubled in the past year, and CEO expects headcount to grow from 16 to at least 30 by next year

Officials seek to build up Ottawa’s burgeoning biotech sector
Local economic development agencies are doing their best to help give the city’s fledgling biotech and medical devices sector a leg up
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
OBJ INSIDER HOLIDAY SAVINGS EVENT. See the full story.